Novartis AG ROE Ratio 2011-2026 | NVS

Annual ROE Ratio Novartis AG

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	14.24	21.12	16.03	-	8.97	23.08	14.43	12.34	13.76	13.84

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
23.08	8.97	15.31

Quarterly ROE Ratio Novartis AG

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
5.38	2.69	8.04	10.7	10.7	5.35	8.81	6.93	6.93	3.46	16.67	26.41	26.41	13.2	23.3	20.2	20.2	10.1	12.93	5.66	5.66	2.83	2.83	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
26.41	2.69	11.1

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	6.05	$ 20.41	-1.4 %	$ 2.57 B	USA
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	-20.19	$ 0.79	-6.51 %	$ 4.31 M	China
Axsome Therapeutics AXSM	-207.46	$ 165.07	-0.79 %	$ 8.21 B	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
AbCellera Biologics ABCL	-15.14	$ 3.76	-1.7 %	$ 1.12 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Burford Capital Limited BUR	10.1	$ 8.57	-1.83 %	$ 1.4 B	Britain
Corvus Pharmaceuticals CRVS	-69.87	$ 18.11	1.23 %	$ 870 M	USA
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
ARCA biopharma ABIO	-21.9	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	156.54	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	-32.19	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	-98.61	$ 26.36	-1.82 %	$ 706 M	USA
Certara CERT	-0.15	$ 7.24	2.62 %	$ 1.16 B	USA
Acasti Pharma ACST	-14.36	-	4.01 %	$ 150 M	Canada
Codexis CDXS	-97.53	$ 1.01	-0.98 %	$ 74.1 M	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-270.67	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-36.89	-	1.93 %	$ 17.4 M	USA
Catalyst Pharmaceuticals CPRX	22.46	$ 23.77	-0.46 %	$ 2.91 B	USA
Agenus AGEN	160.57	$ 3.27	-2.09 %	$ 1.17 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	-34.6	$ 28.85	-1.2 %	$ 1.67 B	USA
Champions Oncology CSBR	124.63	$ 5.98	-1.48 %	$ 81.7 M	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Завод ДИОД DIOD	3.1	-	-	-	Russia
Фармсинтез LIFE	-51.75	-	-	-	Russia
Albireo Pharma ALBO	-19.38	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	-26.25	$ 3.71	-2.43 %	$ 116 M	France
Alector ALEC	-466.34	$ 2.13	-3.39 %	$ 219 M	USA
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	-115.61	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	-76.97	$ 4.22	1.32 %	$ 300 M	USA
Teligent, Inc. TLGT	473.41	-	-13.85 %	$ 16.1 M	USA
AlloVir ALVR	-51.87	-	4.14 %	$ 49.1 M	USA
Viela Bio, Inc. VIE	-40.09	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	-256.9	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	-8.45	$ 14.3	2.66 %	$ 5.93 B	Irlanda
AbbVie ABBV	-55.54	$ 233.44	-0.33 %	$ 413 B	USA